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Abstract
Conventional differential scanning calorimetry (DSC) techniques are commonly used to quantify the solubility of drugs within
polymeric-controlled delivery systems. However, the nature of the DSC experiment, and in particular the relatively slow heating
rates employed, limit its use to the measurement of drug solubility at the drug’s melting temperature. Here, we describe the
application of hyper-DSC (HDSC), a variant of DSC involving extremely rapid heating rates, to the calculation of the solubility
of a model drug, metronidazole, in silicone elastomer, and demonstrate that the faster heating rates permit the solubility to
be calculated under non-equilibrium conditions such that the solubility better approximates that at the temperature of use. At
a heating rate of 400 ◦C/min (HDSC), metronidazole solubility was calculated to be 2.16 mg/g compared with 6.16 mg/g at
20 ◦C/min.
© 2005 Elsevier B.V. All rights reserved.
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1. Introduction
The release characteristics of drugs from diffusion-
controlled polymeric delivery systems are largely
determined by the solubility and diffusivity of the
drug within the cross-linked polymer network (Chien,
1992). However, quantifying the solubility of any sub-
∗ Corresponding author. Tel.: +44 121 204 3903.
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stance within a polymer network is not straightforward.
Simple saturation/filtration solubility studies, as per-
formed for liquid solvents, are clearly not possible,
and exhaustive release into a suitable medium will
not discriminate between dispersed and dissolved drug
(Ahmed et al., 2004). Historically, microscopy has been
used to measure solubility within semi-solid or trans-
parent solids with a lack of crystals indicating that all
drug present is dissolved. The residual liquid sepa-
rated from an ointment on storage has been used to
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estimate the solubility of a drug within it (Koboyashi
and Saitoh, 1998). X-ray powder diffractometry has
been used to measure the solubility of salicylic acid
in a hydrogel (Suryanarayanan et al., 1992), whereby
the intensities of the salicylic acid peaks in the diffrac-
tion trace were linearly related to its weight percent
in the formulations, permitting the solubility of the
acid in the hydrogel to be estimated from the intercept.
However, large degrees of variance were associated
with this method (Suryanarayanan et al., 1992). The
solubility of a drug in silicone oil has been used as
a predictor for solubility within a silicone elastomer
matrix (Malcolm et al., 2003a,b, 2004; Woolfson et al.,
2003); this method assumes that the solubility charac-
teristics within the relatively low molecular weight oil
are similar to those within the cross-linked elastomer.
The use of differential scanning calorimetry (DSC)
for the quantitative measurement of the solubility of
solid drugs dispersed in polymeric matrices was first
described by Theeuwes et al. (1974). The method was
based on the simple principle that the fraction of drug
solubilised within the matrix does not contribute to the
melting endotherm associated with the dispersed drug
fraction. Thus, by plotting the measured Hf values
versus the drug concentrations for a range of loadings
and extrapolating to zero Hf, the solubility of the
drug in the polymer could be estimated. However, the
use of a relatively slow 10 ◦C/min scanning rate, as
is typical for polymeric systems, provides sufficient
time for the molecules within the crystal lattice of the
drug substance to respond to the input of energy dur-
ing the heating ramp by detaching from the lattice and
further dissolving in the polymer matrix. As a conse-
quence, the solubility value determined is that at the
melting temperature of the drug. This DSC method
has since been used to determine the solubility of
propanolol (Bodmeier and Paeratakal, 1989), salicylic
acid and chlorpheniramine (Jenquin and McGinity,
1994), penciclovir (Ahmed et al., 2004), and oxybu-
tynin (Malcolm et al., 2002) in a range of polymer
systems. A similar dynamic mechanical method has
also been used to estimate drug solubility within sil-
icone elastomer. Changes in storage modulus (G′)
associated with melting of the drug within the silicone
matrix were linearly related to drug loading, and extrap-
olation to zero G′ provided an estimate of solubility,
once again at the drug’s melting point (Malcolm et al.,
2002).
Hyper DSC (HDSC) may overcome the disadvan-
tage associated with conventional thermal methods
such as DSC and DMTA for determining solubil-
ity in polymer systems whereby solubility can only
be measured at the drug melting temperature. The
fast heating rates do not inhibit the sample from
responding to the energy imputed (as seen by no
changes in heats of fusion for melt transitions between
heating rates) but can affect and inhibit kinetically
controlled transitions such as recrystallisation, poly-
morph interconversion (McGregor et al., 2004); there-
fore, in this case the high heating rates may inhibit
further solubilisation due to the increase in solubil-
ity profile caused by increasing the temp that may
otherwise occur during slower scans. In order to
demonstrate the utility of this approach, this study
describes the use of HDSC to measure the solubility
of the model drug metronidazole within silicone elas-
tomer.
2. Materials and methods
Crystalline metronidazole (M3761) was purchased
from Sigma, UK. A two-part, platinum-catalysed sil-
icone elastomer system, Silastic 9280/60E was pur-
chased from Dow Corning, USA.
2.1. Preparation of the silicone ﬁlms
Parts A and B of the silicone elastomer kit were
blended in a 1:1 ratio to produce the silicone elastomer
mix. Metronidazole was added and mixed (1, 2.5, 5, 7.5
and 10%, w/w) to produce active elastomer mixes. Each
mix was then placed between two glass microscope
slides separated by 1-mm spacers before curing in a
preheated oven at 80 ◦C for 24 h and then at 120 ◦C for
1 h. The resulting matrices were refrigerated in airtight
containers until required.
2.2. HDSC experimental protocol
HDSC experiments were carried out using a dia-
mond DSC (Perkin-Elmer, Pyris series 5.0), calibrated
for temperature and enthalpy at each heating rate
using an indium standard (Perkin-Elmer). Samples
(4.55± 0.45 mg) were cut from the metronidazole-
loaded silicone matrices and placed in hermetically
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sealed aluminium pans (Perkin-Elmer); an empty pan
was used as a reference in all cases.
Measurements were performed over a temperature
range to include the melting temperature of the drug
(20–250 ◦C). Heating rates of 20, 100 and 400 ◦C/min
were used within the study. Helium was used as the
purge gas (20 mL/min). The calculation of the area
under the transition peak permitted the evaluation of
the energy associated with the phase transition, Hf
and so the calculation of solubility. The area under
the melting endotherm was calculated from the onset
to the end of the peak using the Pyris series 5 data
analysis package, (Perkin-Elmer). A blank (non-drug-
containing) silicone film was also measured to ensure
that there were no background thermal events. It has
already been demonstrated that linear control of heat-
ing rate can be achieved at scan rates up to 500 ◦C/min
using this equipment (Saunders et al., 2004).
3. Results and discussion
The DSC scan of the blank silicone matrix demon-
strated a flat baseline with no thermal events over
the temperature range investigated. Pure metronida-
zole demonstrated a melting endotherm at 160 ◦C at
all scanning rates. The enthalpy of fusion was 163± 3,
158± 3 and 162± 5 J/g at heating rates of 20, 100 and
400 ◦C/min, respectively, with no significant difference
in this value at all heating rates investigated. However,
the size of the endotherm increased dramatically as
the scan rate increased, this is because DSC output is
measured in mW (mJ/s); therefore, faster heating rates
increase the size of the power signal due to an alter-
ation in heat capacity (J/(g ◦C)). Fig. 1 clearly shows
that increasing the heating rate increases the peak mag-
nitude, this trend is similar to that observed by Saunders
et al. (2004).
Metronidazole-loaded silicone matrices (1, 2.5, 5,
7.5 and 10%, w/w) were prepared and investigated at
scan rates of 20, 100 and 400 ◦C/min. Fig. 2 shows
the effect of increasing drug concentration on the melt-
ing endotherm, with higher concentrations causing the
size of the melting endotherm to increase, as it relates
to the concentration of undissolved drug present in
the formulation at the melting temperature. By plot-
ting Hf against the drug loading concentration and
extrapolating to zero Hf, as in Fig. 3, the solubility
of metronidazole in the silicone matrix may be deter-
mined. Linear trend lines were fitted using Microsoft
Excel with regression values in each case being greater
than 0.99. The solubility values, calculated as the x-
intercept using these trend lines, were: 0.616% (w/w)
(20 ◦C/min), 0.493% (w/w) (100 ◦C/min) and 0.216%
(w/w) (400 ◦C/min). Microscopically, the solution pro-
cess of a drug crystal in a polymer composition can
be visualised as consisting of two consecutive steps:
(i) the dissociation of drug molecules from the crys-
Fig. 1. Typical melting endotherms obseved for metronidazole (10%, w/w) in silicone at heating rates of 20 (– - –), 100 (– – –) and 400 ◦C/min
(—).
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Fig. 2. DSC Data at 400 ◦C/min heating rate of the 1 (– - - –), 2.5 (– - –), 5(– – –), 7.5 (- - -) and 10% (—) (w/w) metronidazole:silicone samples.
tal lattice and (ii) the solvation of these dissociated
molecules into the surrounding polymer. Given that
the first step is also involved in the melting process,
it is apparent that the observed decrease in solubility
with increasing heating rate must be largely attributed
to the time-dependent solvation process. The faster
heating rates provide insufficient time for the drug
molecules to dissolve in the polymer. This study shows
that the solubility calculated was dependant on the scan
rate used, however, the faster the scan rate the better
the prediction of solubility as the kinetic events are
minimised.
The 0.616% (w/w) solubility value for metronida-
zole in silicone elastomer obtained at 20 ◦C/min using
Fig. 3. An example of a plot of metronidazole concentration against
the enthalpy of fusion ((©) 20, ( )100 and () 400 ◦C/min heating
rate), n= 4.
conventional DSC is comparable to that calculated
previously for the solubility of metronidazole in low
viscosity silicone oil (0.006 mg cm−3 or 0.06%, w/w)
(Malcolm et al., 2003a,b). However, the former value
is likely to overestimate the solubility for the reasons
outlined earlier, while the latter value does not take
account of the very real physicochemical differences
between liquid silicone and silicone elastomer, as dis-
cussed in previous studies (Malcolm et al., 2002). The
value of 0.216% (w/w) obtained by the HDSC method
at 400 ◦C/min is a more realistic estimate in that it is
measured in silicone elastomer under conditions that
serve to minimize the effects of temperature on solu-
bility.
4. Conclusions
This study has shown that hyper DSC offers a sim-
ple, fast and effective way to measure the solubility of
a drug within a solid polymer matrix. Faster heating
rates reduce further dissolution of drug into the matrix
with heating and thus a more realistic estimation of sil-
icone solubility at working temperature is provided. In
this case a solubility of 0.216% (w/w) metronidazole
in silicone was predicted using HDSC. Solubility pre-
diction is dependant upon the scan rate used, the high
speed DSC enables data to be collected at higher heat-
ing rates with no loss in quality of data, thus fast scan
rates should be used where possible.
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